No Data
If You Invested $1000 In Gilead Sciences Stock 20 Years Ago, You Would Have This Much Today
Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 2.04% on an annualized basis producing an average annual return of 11.31%. Currently, Gilead Sciences has a market
MacroGenics Announces Gilead Sciences Exercises Option For Exclusive License To Preclinical Bispecific Program Under 2022 Collaboration, Triggering $10M Payment
MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Gilead
$1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 1.15% on an annualized basis producing an average annual return of 14.61%. Currently, Thermo Fisher
SA Analyst Upgrades/downgrades: INTC, AMD, ANET, GILD
$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years by 1.65% on an annualized basis producing an average annual return of 14.88%. Currently, Amgen has a market capitalization of $22
Ten Large-cap Healthcare Stocks With Strong Quant Scores Amid Sector-wide Rally